In pediatric SMA patients, baseline serum levels of IL-1β, IL-4, IL-6, IL-10, IFN-γ, IL-17A, IL-17F, IL-22, IL-23, IL-31, IL-33, and TNF-α were significantly elevated compared to reference ranges [125]. This evidence concerns the gene IL17A and proximal spinal muscular atrophy.